Stefan Peter Mortensen

Stefan Peter Mortensen

Auto-generated profile, based on publicly available information

Stefan Peter Mortensen

Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2013 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
LGLasse Gliemann
Lasse Gliemann
JSJakob Friis Schmidt
Jakob Friis Schmidt
JOJesper Olesen
Jesper Olesen
RBRasmus Sjørup Biensø
Rasmus Sjørup Biensø
SPSebastian Louis Peronard
Sebastian Louis Peronard
YHYlva Hellsten
Ylva Hellsten
Key points: In rodents, resveratrol has been shown to enhance training‐induced changes in cardiovascular function, exercise performance and the retardation of atherosclerosis. We examined the effect of 8 weeks of exercise training with and without concomitant resveratrol supplementation in aged men. Exercise training potently improved blood pressure, blood cholesterol, maximal oxygen uptake and the plasma lipid profile. Resveratrol supplementation reduced the positive effect of exercise training on blood pressure, blood cholesterol and maximal oxygen uptake and did not affect the retardation of atherosclerosis. Whereas exercise training improved formation of the vasodilator prostacyclin, concomitant resveratrol supplementation caused a shift in vasoactive systems favouring vasoconstriction. The present study is the first to demonstrate negative effects of resveratrol on training‐induced improvements in cardiovascular health parameters in humans and adds to the growing body of evidence questioning the positive effects of resveratrol supplementation in humans. Abstract  Ageing is thought to be associated with decreased vascular function partly due to oxidative stress. Resveratrol is a polyphenol, which in animal studies has been shown to decrease atherosclerosis, and improve cardiovascular health and physical capacity, in part through its effects on Sirtuin 1 signalling and through an improved antioxidant capacity. We tested the hypothesis that resveratrol supplementation enhances training‐induced improvements in cardiovascular health parameters in aged men. Twenty‐seven healthy physically inactive aged men (age: 65 ± 1 years; body mass index: 25.4 ± 0.7 kg m−2; mean arterial pressure (MAP): 95.8 ± 2.2 mmHg; maximal oxygen uptake: 2488 ± 72 ml O2 min−1) were randomized into 8 weeks of either daily intake of either 250 mg trans‐resveratrol (n= 14) or of placebo (n= 13) concomitant with high‐intensity exercise training. Exercise training led to a 45% greater (P < 0.05) increase in maximal oxygen uptake in the placebo group than in the resveratrol group and to a decrease in MAP in the placebo group only (−4.8 ± 1.7 mmHg; P < 0.05). The interstitial level of vasodilator prostacyclin was lower in the resveratrol than in the placebo group after training (980 ± 90 vs. 1174 ± 121 pg ml−1; P < 0.02) and muscle thromboxane synthase was higher in the resveratrol group after training (P < 0.05). Resveratrol administration also abolished the positive effects of exercise on low‐density lipoprotein, total cholesterol/high‐density lipoprotein ratio and triglyceride concentrations in blood (P < 0.05). Resveratrol did not alter the effect of exercise training on the atherosclerosis marker vascular cell adhesion molecule 1 (VCAM‐1). Sirtuin 1 protein levels were not affected by resveratrol supplementation. These findings indicate that, whereas exercise training effectively improves several cardiovascular health parameters in aged men, concomitant resveratrol supplementation can blunt these effects.

1 July 2005 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
SMStefan P. Mortensen
Stefan P. Mortensen
EDEllen Adele Dawson
Ellen Adele Dawson
CYChie C. Yoshiga
Chie C. Yoshiga
MDMads K. Dalsgaard
Mads K. Dalsgaard
RDRasmus Damsgaard
Rasmus Damsgaard
JGJosé González‐Alonso
José González‐Alonso

31 January 2018 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
KWKamilla Munch Winding
Kamilla Munch Winding
GMGregers Winding Munch
Gregers Winding Munch
UIUlrik Winning Iepsen
Ulrik Winning Iepsen
GHGerrit Van Hall
Gerrit Van Hall
BPBente Klarlund Pedersen
Bente Klarlund Pedersen
SMStefan Peter Mortensen
Stefan Peter Mortensen

22 October 2012 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
YHYlva Hellsten
Ylva Hellsten
MNM. Nyberg
M. Nyberg
LJL. G. Jensen
L. G. Jensen
SMS. P. Mortensen
S. P. Mortensen
Abstract During exercise, oxygen delivery to skeletal muscle is elevated to meet the increased oxygen demand. The increase in blood flow to skeletal muscle is achieved by vasodilators formed locally in the muscle tissue, either on the intraluminal or on the extraluminal side of the blood vessels. A number of vasodilators have been shown to bring about this increase in blood flow and, importantly, interactions between these compounds seem to be essential for the precise regulation of blood flow. Two compounds stand out as central in these vasodilator interactions: nitric oxide (NO) and prostacyclin. These two vasodilators are both stimulated by several compounds, e.g. adenosine, ATP, acetylcholine and bradykinin, and are affected by mechanically induced signals, such as shear stress. NO and prostacyclin have also been shown to interact in a redundant manner where one system can take over when formation of the other is compromised. Although numerous studies have examined the role of single and multiple pharmacological inhibition of different vasodilator systems, and important vasodilators and interactions have been identified, a large part of the exercise hyperaemic response remains unexplained. It is plausible that this remaining hyperaemia may be explained by cAMP‐ and cGMP‐independent smooth muscle relaxation, such as effects of endothelial derived hyperpolarization factors (EDHFs) or through metabolic modulation of sympathetic effects. The nature and role of EDHF as well as potential novel mechanisms in muscle blood flow regulation remain to be further explored to fully elucidate the regulation of exercise hyperaemia.

15 May 2008 in The Journal of Physiology
Verified
Journal Article
Closed access
SMStefan P. Mortensen
Stefan P. Mortensen
RDRasmus Damsgaard
Rasmus Damsgaard
EDEllen Adele Dawson
Ellen Adele Dawson
NSNiels H. Secher
Niels H. Secher
JGJosé González-Alonso
José González-Alonso

23 May 2007 in The Journal of Physiology
Verified
Journal Article
Closed access
SMStefan P. Mortensen
Stefan P. Mortensen
JGJosé González‐Alonso
José González‐Alonso
RDRasmus Damsgaard
Rasmus Damsgaard
BSBengt Saltin
Bengt Saltin
YHYlva Hellsten
Ylva Hellsten